• About us
• Contact

Advertisement

Organisation › Details

Repligen (Group)

Repligen Corporation is a life sciences tools and technology company that develops and markets highly innovative bioprocessing solutions and systems. Our products enable efficiencies in the process of manufacturing a wide range of biological drugs, including: monoclonal antibodies; recombinant proteins; cell and gene therapies; and vaccines. We are inspiring advances in bioprocessing for the customers we serve around the globe; primarily biopharmaceutical companies and contract development and manufacturing organizations (CDMOs). Our corporate headquarters are located in Waltham, Massachusetts, with additional administrative and manufacturing operations worldwide. The majority of our manufacturing sites are located within the U.S. (California, Massachusetts, New Jersey and New York), and outside of the U.S. we have sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. *

 

	Start	1991-01-01 existent
	Today	Repligen Corporation (Nasdaq: RGEN)
	Industry	biopharmaceutical production technology (biomanufacturing)
	Industry 2	laboratory equipment and instruments
	Region	Waltham, MA
	Country	United States (USA)
	City	n. a. Waltham, MA
		Address record changed: 2025-09-07
Basic data	Employees	n. a.
		* Document for »About Section«: Repligen Corporation. (8/22/25). "Press Release: Repligen Corporation to Present at Upcoming September Conferences". Waltham, MA.
		Record changed: 2025-09-07

Advertisement

More documents for Repligen (Group)

• [1] Repligen Corporation. (8/22/25). "Press Release: Repligen Corporation to Present at Upcoming September Conferences". Waltham, MA....
• [2] Sartorius AG. (8/17/23). "Press Release: Sartorius and Repligen Corporation Launch Integrated System with Biostat STR and XCell ATF for Upstream Process Intensification". Göttingen....
• [3] 908 Devices, Inc.. (3/7/22). "Press Release: 908 Devices Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Revenue Outlook". Boston, MA....
• [4] 908 Devices, Inc.. (3/2/22). "Press Release: 908 Devices Appoints Tony J. Hunt, President and CEO, Repligen, to Its Board of Directors"....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.